Table 1 Pretreatment characteristics of patients not opting for the immunotherapy limb of the study
MACM malmoenseM xenopiAll 3 species
REClari(n = 47)RECipro(n = 50)REClari(n = 43)RECipro(n = 40)REClari(n = 11)RECipro(n = 10)REClari(n = 101)RECipro(n = 100)
Sex (M/F)25/2220/3030/1324/1610/17/365/3651/49
Mean (SD) age (years)67.3 (11.6)64.6 (12.5)62.7 (11.4)62.7 (12.3)61.7 (11.1)62.8 (10.3)64.7 (11.6)63.7 (12.1)
BCG vaccination7 (15%)9 (18%)3 (7%)6 (15%)3 (27%)1 (10%)13 (13%)16 (16%)
Cavitation33 (70%)32 (64%)17 (40%)18 (45%)9 (82%)8 (80%)59 (58%)58 (58%)
⩾3 zones8 (17%)5 (10%)9 (21%)5 (13%)1 (9%)3 (30%)18 (18%)13 (13%)
Other pulmonary disease on chest radiograph29 (62%)26 (52%)8 (19%)16 (40%)8 (73%)8 (80%)45 (45%)50 (50%)
  • Cipro, ciprofloxacin; Clari, clarithromycin; E, ethambutol; MAC, Mycobacterium avium intracellulare; R, rifampicin.